Table 1 Infection control strategies used
From: Current infection control practices used in Australian and New Zealand cystic fibrosis centers
|  | Pediatric-treating services (n = 38) | Adult-treating services (n = 22) | p-value | ≤200 patients (n = 52) | > 200 patients (n = 8) | p-value |
|---|---|---|---|---|---|---|
Implementation of CF-specific infection control policy, n (%) | 37/38 (97%) | 18/22 (82%) | 0.23 | 47/50 (94%) | 8/8 (100%) | 1.00 |
Contact precautions | ||||||
 During hospital admission: |  |  |  | NA | NA | NA |
  All people with CF, n (%) | 6/19 (32%) | 8/9 (89%) | 0.013 |  |  |  |
  MRSA infection, n (%) | 26/29 (90%) | 16/16 (100%) | 0.54 |  |  |  |
  MRO infection, n (%) | 15/21 (71%) | 11/12 (92%) | 0.22 |  |  |  |
 During ambulatory care: |  |  |  | NA | NA | NA |
  All people with CF, n (%) | 4/32 (13%) | 4/18 (22%) | 0.44 |  |  |  |
  MRSA infection, n (%) | 13/32 (41%) | 7/18 (39%) | 0.90 |  |  |  |
  MRO infection, n (%) | 9/26 (35%) | 6/18 (33%) | 0.93 |  |  |  |
  Patient mask wearing policy | 24/37 (65%) | 12/22 (55%) | 0.43 | 29/51 (57%) | 7/8 (88%) | 0.13 |
 Use of face-masks (regardless of whether mask-policy implemented): |  |  | 1.00 |  |  | 0.25 |
  Surgical mask, n (%) | 22/30 (73%) | 11/14 (79%) |  | 27/37 (73%) | 6/7 (86%) |  |
  N95 mask, n (%) | 2/30 (7%) | 1/14 (7%) |  | 2/37 (5%) | 1/7 (14%) |  |
  Combination of mask types/other mask types, n (%) | 6/30 (20%) | 2/14 (14%) |  | 8/37 (22%) | 0/7 (0%) |  |
Segregation strategies | ||||||
 Hospital rooms used: |  |  | 0.69 |  |  | 0.21 |
  Single room with ensuite only^, n (%) | 19/31 (61%) | 10/18 (56%) |  | 27/43 (63%) | 2/6 (33%) |  |
  Combination of room types, n (%) | 12/31 (39%) | 8/18 (44%) |  | 16/43 (37%) | 4/6 (67%) |  |
 During ambulatory care: |  |  | 0.51 |  |  | 0.38 |
  Segregated waiting areas, n (%) | 28/35 (80%) | 13/19 (68%) |  | 36/46 (78%) | 5/8 (63%) |  |
  Communal waiting areas, n (%) | 7/35 (20%) | 6/19 (32%) |  | 10/46 (22%) | 3/8 (38%) |  |